Comparison of no-test telehealth and in-person medication abortion

JAMA

2024-06-24

(Press-News.org) About The Study: This prospective, observational study found that medication abortion obtained following no-test telehealth screening and mailing of medications was associated with similar rates of complete abortion compared with in-person care with ultrasonography and met prespecified criteria for noninferiority, with a low prevalence of adverse events.

Quote from corresponding author Lauren J. Ralph, Ph.D., M.P.H.:

“This is a prospective, observational study comparing patients who received medication abortion care remotely and without ultrasound to those who went in person to a facility and got an ultrasound. Using data from patient surveys and their medical record, we found no differences in effectiveness of medication abortion by how they received the medications, and low prevalence of adverse events across all groups.

“No-test, telehealth medication abortion is as effective as in person care with ultrasound, and safe overall. This model of care should be offered as an option to all pregnant people seeking abortion.

“I hope that these findings are reassuring to both clinicians and patients that medication abortion using no-test, telehealth and mailing of medications is as effective as in person care with ultrasound. These models offer a safe, effective and urgently needed way to overcome logistical and geographic obstacles to accessing abortion today.

“Despite continued efforts to restrict access to medication abortion, for example by requiring in person dispensing of the medications, the research has consistently been clear that medication abortion with no-test eligibility assessment and mailing of medications is just as effective as in person care with ultrasound.”

Contact information for Lauren J. Ralph, Ph.D., M.P.H.: email Lauren.Ralph@ucsf.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.10680)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10680?guestAccessKey=9a062794-a7aa-4674-9b7e-e3fb459b4f45&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

END

ELSE PRESS RELEASES FROM THIS DATE:

3D maps of diseased tissues at subcellular precision

2024-06-24

An open-source platform developed by researchers in Nikolaus Rajewsky’s lab at the Max Delbrück Center creates molecular maps from patient tissue samples with subcellular precision, enabling detailed study and potentially enhancing routine clinical pathology. The study was published in “Cell.” Researchers in the Systems Biology Lab of Professor Nikolaus Rajewsky have developed a spatial transcriptomics platform, called Open-ST, that enables scientists to reconstruct gene expression in cells within a tissue in three ...

Estimated effectiveness of Pfizer-BioNTech vaccine against COVID-19

2024-06-24

About The Study: The findings of this case-control study reaffirm current recommendations for broad age-based use of annually updated COVID-19 vaccines given that (1) the BNT162b2 XBB vaccine (Pfizer-BioNTech; 2023-2024 formulation) provided statistically significant additional protection against a range of COVID-19 outcomes and (2) older versions of COVID-19 vaccines offered little, if any, long-term protection, including against hospital admission, regardless of the number or type of prior doses received. Corresponding Author: To contact the ...

New study shows medication abortion without ultrasound to be safe

2024-06-24

Researchers compared patients who received care remotely to those who got ultrasounds and found no differences in outcomes.  Medication abortion patients who receive pills by mail without first getting an ultrasound do just as well as those who are examined and given the drugs in person, new research from UC San Francisco has found. The study, which appears June 24 in JAMA, adds to evidence from UCSF’s Advancing New Standards in Reproductive Health (ANSIRH) program that using telehealth for medication abortion is safe and effective.  Although the ...

New approach accurately identifies medications most toxic to the liver

2024-06-24

The current method for assessing medication-related liver injury is not providing an accurate picture of some medications’ toxicity—or lack thereof—to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Classification of a medication’s potential to damage the liver, termed “hepatotoxicity,” has been historically determined by counting individual reported cases of acute liver injury (ALI). Instead, the researchers used real-world health care data to measure rates of ALI within a population and uncovered that some medications’ levels of danger to the liver ...

Study reveals new opportunities to develop cancer treatments

2024-06-24

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating this disease. Using a comprehensive approach that included integrating proteomics, genomics and epigenomics data from 10 cancer types, the team identified protein and small protein or peptide targets in cancer tissues and validated many of them experimentally as promising candidates for therapeutic strategies. The study appeared in Cell. “Experience ...

Bezos Center for Sustainable Protein launches at Imperial with $30M funding

2024-06-24

Bezos Earth Fund grant establishes new Centre at Imperial to transform global food systems from environmentally damaging to innovative by creating sustainable solutions. Imperial’s Bezos Centre for Sustainable Protein, launched today, will develop innovative and evidence-based solutions through the design, delivery, and commercialisation of alternative food products that are economically and environmentally friendly, nutritious, affordable, and tasty. The Centre, spanning across seven Imperial academic departments, will advance research into precision fermentation, cultivated meat, bioprocessing and automation, ...

Star clusters observed within a galaxy in the early Universe for the first time

2024-06-24

The history of how stars and galaxies came to be and evolved into the present day remains among the most challenging astrophysical questions to solve yet, but new research brings us closer to understanding it. In a new study by an international team led by Dr. Angela Adamo at Stockholm University, new insights about young galaxies during the Epoch of Reionization have been revealed. Observations with the James Webb Space Telescope (JWST) of the galaxy Cosmic Gems arc (SPT0615-JD) have confirmed that the light of the galaxy was emitted 460 million years after ...

How much oxygen do very premature babies need after birth?

2024-06-24

Giving very premature babies high concentrations of oxygen soon after birth may reduce the risk of death by 50 percent, compared to lower levels of oxygen says new research led by University of Sydney researchers. When premature babies are born, they sometimes need help breathing because their lungs haven’t finished developing. To help babies during this process, doctors may give them extra oxygen through a breathing mask or breathing tube. The study, published in JAMA Pediatrics, examined clinical trial data and outcomes of ...

Trial offers hope for cheaper, more tolerable, ketamine treatment

2024-06-24

For those suffering from treatment-resistant depression, the anaesthetic drug ketamine offers hope, but it has side effects and can be costly to access – a University of Otago-led clinical trial may change that. Working in collaboration with New Zealand’s Douglas Pharmaceuticals, researchers have conducted a trial of ketamine in an extended-release tablet form. The study, published in prestigious international journal Nature Medicine, involved 168 adults for whom regular anti-depressant therapy ...

Fertility treatments could get boost from stem cells

2024-06-24

An unexpectedly versatile and regenerative stem cell in early embryos may be key to creating new effective fertility treatments, suggests a new study in mice from the University of Copenhagen. It probably will not surprise anyone that pregnancy is a very complicated process. First, a sperm cell must find its way and fertilize an egg in the fallopian tube, after which the egg begins to divide. After about five days, the egg becomes a blastocyst, which eventually develops into a fetus. But for more and more people, fertility is becoming increasingly harder to achieve due to various factors ...

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

Comparison of no-test telehealth and in-person medication abortion

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: